2035年中医药研究可能面临的机遇与挑战
本文探讨人工智能等现代生物与信息技术融入药物研发全流程对中医药研究的影响。作为涵盖草药、针灸与气功的悠久治疗体系,中医药未来十年将在与现代技术理念融合中面临机遇与挑战。到2035年,中医药有望通过更现代开放的研究开发模式与现代医学融合,为治疗更广泛疾病提供支持。
要点
- 现代生物与信息技术正渗透药物研发各阶段,有望提升研发效率与成功率。
- 中医药涵盖草药、针灸与气功,将受这些技术进展的深刻影响。
- 未来十年中医药研究在融合现代技术理念时面临机遇与挑战。
核心结论
- 到2035年,中医药有望通过更现代开放的研究开发模式与现代医学融合,为治疗更广泛疾病提供支持。
主要发现
- 现代生物与信息技术的快速进步,如人工智能,正使药物开发流程面临重大转变。
- 这些新技术与理念渗透药物开发各阶段,预计将大幅提升研发效率与成功率。
- 中医药作为涵盖草药、针灸与气功的悠久治疗体系,也将受到这些进展的深刻影响。
- 未来十年,中医药研究在融合现代技术与理念时将同时遇到机遇与挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The drug development process is poised for significant transformation due to the rapid advancement of modern biological and information technologies, such as artificial intelligence (AI). As these new technologies and concepts infiltrate every stage of drug development, the efficiency and success rate of research and development are expected to improve substantially. Traditional Chinese medicine (TCM), a time-honored therapeutic system encompassing herbal medicine, acupuncture, and qigong, will also be profoundly impacted by these advancements. Over the next decade, Traditional Chinese medicine research will encounter both opportunities and challenges as it integrates with modern technologies and concepts. By 2035, TCM is anticipated to merge with modern medicine through a more contemporary and open research and development model, providing substantial support for treating a broader spectrum of diseases.
引用
- Huang N, Huang W, Wu J, et al. Possible opportunities and challenges for traditional Chinese medicine research in 2035. Front Pharmacol. 2024. PMID: 38974044. doi:10.3389/fphar.2024.1426300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。